This inventor holds 6 USPTO granted patents. Top assignees: Maggioni Farmaceutici, S.p.a., Maggioni-Winthrop S.p.a., Maggioni and C.. Active years: 1978-1990.
Location History:
- Monza, IT (1986)
- Milan, IT (1978 - 1990)
Company Filing History:
Years Active: 1978-1990
Title: Innovator Franco Ravenna: A Pillar in Pharmaceutical Advancements
Introduction
Franco Ravenna, an accomplished inventor based in Milan, Italy, has made significant contributions to the field of pharmaceuticals with his groundbreaking innovations. With a record of six patents to his name, Ravenna's work primarily focuses on compounds that exhibit vital pharmacological activities. His dedication to advancing medical science has positioned him as a noteworthy figure in the industry.
Latest Patents
Among his latest patents are key innovations such as Bicyclic alkoxy- and alkylthio-substituted aminoalcohols and Fused cycloaliphatic aminoalcohols. These inventions are pivotal in the development of new treatments, particularly for conditions related to hypertension and other cardiovascular issues. The compounds Ravenna developed demonstrate pharmacological activity as anti-hypertensive agents, platelet aggregation inhibitors, hypolipemic agents, antianoxic substances, and spasmolytics. The generic formula for these compounds showcases their complexity and potential therapeutic benefits.
Career Highlights
Ravenna's career includes significant tenures at notable companies such as Maggioni Winthrop S.p.a. and Maggioni Farmaceutici S.p.a. His contributions within these institutions highlight his expertise in pharmaceutical innovation and his ability to translate scientific research into practical healthcare solutions.
Collaborations
Throughout his career, Franco Ravenna has collaborated with esteemed colleagues like Giampaolo Picciola and Mario Riva. These partnerships underscore the collaborative nature of scientific research and the importance of teamwork in driving forward innovation in medicine.
Conclusion
Franco Ravenna stands as a remarkable inventor whose patents have the potential to transform therapeutic practices in the pharmaceutical industry. His commitment to research and collaboration reflects the essence of innovation, paving the way for future advancements in healthcare.